Watson Pharmaceuticals Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
2.65 Bil |
| Income |
221.49 Mil |
| Net Profit Margin |
8.35% |
| Return on Equity |
10.16% |
| Debt/Equity Ratio |
0.43 |
|
| Revenue/Share |
22.48 |
| Earnings/Share |
1.94 |
| Book Value/Share |
21.80 |
| Dividend Rate |
0.00 |
| Payout Ratio |
0.00% |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 667.4 | 626.9 | 671.6 |
| 2nd Qtr | 677.8 | 622.6 | 603.0 |
| 3rd Qtr | 662.1 | 640.7 | 594.7 |
| 4th Qtr | NA | 645.2 | 627.3 |
| Total | 2,007.3 | 2,535.5 | 2,496.7 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | $0.48 | $0.49 | $0.31 |
| 2nd Qtr | $0.51 | $0.59 | $0.36 |
| 3rd Qtr | $0.61 | $0.69 | $0.34 |
| 4th Qtr | NA | $0.55 | $0.33 |
| Total | $1.60 | $2.32 | $1.34 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -13% | 48% | --- |
| 2nd Qtr | 6% | 20% | 16% |
| 3rd Qtr | 20% | 17% | -6% |
| 4th Qtr | NA | -20% | -3% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | -2% | 58% |
| 2nd Qtr | -14% | 64% |
| 3rd Qtr | -12% | 103% |
| 4th Qtr | NA | 67% |
advertisement
Recent News